|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/145 | (2006.01) |
| C12Q 1/70 | (2006.01) |
| (11) | Number of the document | 2179744 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09075377.3 |
| Date of filing the European patent application | 2005-09-09 | |
| (97) | Date of publication of the European application | 2010-04-28 |
| (45) | Date of publication and mention of the grant of the patent | 2010-12-01 |
| (46) | Date of publication of the claims translation | 2011-03-25 |
| (30) | Number | Date | Country code |
| 04255471 | 2004-09-09 | EP |
| (72) |
Gregersen, Jens Peter, DE
|
| (73) |
Novartis Vaccines and Diagnostics GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Galimos jatrogeninės rizikos, susijusios su gripo vakcinomis, sumažinimas |
| Decreasing potential latrogenic risks associated with influenza vaccines |
| Payment date | Validity (years) | Amount | |
| 2013-08-14 | 9 | 720.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-09-09 |